Northern Trust Corp Uro Gen Pharma Ltd. Transaction History

Northern Trust Corp

  • $658 Billion
  • Q1 2025

A detailed history of Northern Trust Corp transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 285,614 shares of URGN stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
285,614
Previous 310,074 7.89%
Holding current value
$2.37 Million
Previous $3.3 Million 4.36%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$9.27 - $12.13 $226,744 - $296,699
-24,460 Reduced 7.89%
285,614 $3.16 Million
Q4 2024

Feb 14, 2025
BUY
$10.52 - $13.11 $245,589 - $306,052
23,345 Added 8.14%
310,074 $3.3 Million
Q3 2024

Nov 13, 2024
BUY
$12.7 - $17.92 $880,960 - $1.24 Million
69,367 Added 31.91%
286,729 $3.64 Million
Q2 2024

Aug 14, 2024
SELL
$12.72 - $19.2 $192,555 - $290,649
-15,138 Reduced 6.51%
217,362 $3.65 Million
Q1 2024

May 14, 2024
SELL
$13.81 - $19.33 $37,784 - $52,886
-2,736 Reduced 1.16%
232,500 $3.49 Million
Q4 2023

Feb 13, 2024
BUY
$10.87 - $15.93 $628,775 - $921,470
57,845 Added 32.61%
235,236 $3.53 Million
Q3 2023

Nov 13, 2023
SELL
$8.84 - $22.64 $15,841 - $40,570
-1,792 Reduced 1.0%
177,391 $2.49 Million
Q2 2023

Aug 11, 2023
BUY
$8.75 - $14.29 $1.38 Million - $2.25 Million
157,725 Added 735.04%
179,183 $1.85 Million
Q1 2023

May 15, 2023
SELL
$7.99 - $11.02 $2,900 - $4,000
-363 Reduced 1.66%
21,458 $198,000
Q4 2022

Feb 13, 2023
SELL
$7.55 - $11.96 $1,336 - $2,116
-177 Reduced 0.8%
21,821 $193,000
Q3 2022

Nov 14, 2022
BUY
$7.21 - $9.41 $7,267 - $9,485
1,008 Added 4.8%
21,998 $183,000
Q2 2022

Aug 12, 2022
SELL
$5.12 - $8.74 $716,236 - $1.22 Million
-139,890 Reduced 86.95%
20,990 $172,000
Q1 2022

May 13, 2022
SELL
$5.92 - $9.73 $49,852 - $81,936
-8,421 Reduced 4.97%
160,880 $1.4 Million
Q4 2021

Feb 08, 2022
BUY
$9.03 - $19.13 $11,531 - $24,429
1,277 Added 0.76%
169,301 $1.61 Million
Q3 2021

Nov 15, 2021
SELL
$14.31 - $18.39 $422,574 - $543,056
-29,530 Reduced 14.95%
168,024 $2.83 Million
Q2 2021

Aug 13, 2021
SELL
$15.2 - $20.94 $148,078 - $203,997
-9,742 Reduced 4.7%
197,554 $3.02 Million
Q1 2021

May 12, 2021
SELL
$17.99 - $26.96 $577,191 - $864,984
-32,084 Reduced 13.4%
207,296 $4.04 Million
Q4 2020

Feb 11, 2021
SELL
$17.54 - $25.43 $115,465 - $167,405
-6,583 Reduced 2.68%
239,380 $4.31 Million
Q3 2020

Nov 16, 2020
BUY
$18.81 - $26.42 $907,469 - $1.27 Million
48,244 Added 24.4%
245,963 $4.75 Million
Q2 2020

Aug 14, 2020
SELL
$16.5 - $29.7 $533,082 - $959,547
-32,308 Reduced 14.05%
197,719 $5.17 Million
Q1 2020

May 14, 2020
BUY
$13.68 - $34.6 $30,971 - $78,334
2,264 Added 0.99%
230,027 $4.1 Million
Q4 2019

Feb 14, 2020
BUY
$21.11 - $34.86 $85,622 - $141,392
4,056 Added 1.81%
227,763 $7.6 Million
Q3 2019

Nov 13, 2019
BUY
$23.83 - $36.44 $4.01 Million - $6.14 Million
168,371 Added 304.27%
223,707 $5.33 Million
Q2 2019

Aug 13, 2019
BUY
$32.75 - $40.35 $954,400 - $1.18 Million
29,142 Added 111.25%
55,336 $1.99 Million
Q1 2019

May 13, 2019
BUY
$35.47 - $54.55 $304,900 - $468,911
8,596 Added 48.85%
26,194 $968,000
Q4 2018

Feb 12, 2019
BUY
$38.35 - $50.39 $61,360 - $80,624
1,600 Added 10.0%
17,598 $758,000
Q3 2018

Nov 14, 2018
BUY
$41.65 - $51.7 $99,960 - $124,080
2,400 Added 17.65%
15,998 $756,000
Q2 2018

Aug 14, 2018
BUY
$48.35 - $65.33 $657,463 - $888,357
13,598 New
13,598 $677,000

Others Institutions Holding URGN

# of Institutions
142
Shares Held
41.6M
Call Options Held
91.4K
Put Options Held
42.1K
View Full List

About UroGen Pharma Ltd.

URGN Quotes by TradingView
  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $189M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email